Barclays Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock Price
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target lowered by analysts at Barclays from $19.00 to $18.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target points to a potential upside of 52.28% from the stock’s current price. […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target lowered by analysts at Barclays from $19.00 to $18.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Barclays‘s price target points to a potential upside of 52.28% from the stock’s current price. […]
